SPOTLIGHT -
Regdanvimab—A New Attack of the (Mono)Clones
A review of the neutralizing antibody that was studied in a phase 2/3 trial in outpatients with mild to moderate infections of COVID-19.
Read More
Shoutout to the Stewards: Holiday Edition
Contagion® radio is here to bring joy with every new antibiotic alert!
Postulates About the Prostate: Fosfomycin for Chronic Bacterial Prostatitis
Fosfomycin is an attractive potential option because it does not cross-react with other antimicrobials, making it a good choice in patients with extensive drug allergies.